Epigenetic ageing during the COVID-19 pandemic: global age acceleration, independent of SARS-CoV-2 infection.

Publication date: May 26, 2026

The COVID-19 pandemic had profound effects for both infected and uninfected individuals. We aimed to identify acute and chronic epigenetic alterations from SARS-CoV-2 infection and/or lockdown measures. Both infected and uninfected participants from the TwinsUK cohort (n = 139) provided longitudinal whole-blood samples (Spring 2020, Spring 2021). Cross-sectional and longitudinal DNA methylome [DNAm] changes, including epigenetic ageing clocks, were assessed, and EWAS (Epigenome-Wide Association Studies) were performed. Changes in epigenetic ageing clocks were compared with longitudinal samples from an independent pre-pandemic cohort (n = 35, Nurses’ Health Study II cohort), assessed similarly. Irrespective of SARS-CoV-2 infection, all individuals exhibited accelerated ageing from 2020 to 2021 (GrimAge clock age acceleration: p-value = 0. 002, β = 0. 99). In contrast, epigenetic data from paired samples from a separate pre-pandemic cohort, over a similar time period and assessed similarly, did not exhibit GrimAge acceleration. Epigenetic ageing did not differ between infected and uninfected individuals, or between recent and distant SARS-CoV-2 infection. Lastly, EWAS identified several putative changes in DNAm associated with recent, and distant, SARS-CoV-2 infection. Our longitudinal results suggest that the pandemic accelerated epigenetic ageing rates, irrespective of recent or distant SARS-CoV-2 infection.

Open Access PDF

Concepts Keywords
Dnam COVID-19
Global Epigenetic ageing
Nurses Epigenetic clocks
Pandemic Lockdown

Semantics

Type Source Name
disease MESH COVID-19 pandemic
pathway REACTOME SARS-CoV-2 Infection
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Potassium Chloride
disease MESH NHS
pathway REACTOME Methylation
drug DRUGBANK L-Phenylalanine
disease MESH infection
drug DRUGBANK Hexocyclium
disease MESH re infection
drug DRUGBANK Coenzyme M
disease MESH mul

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *